Drug search by name

Ritalin and Hematologic toxicity

Result of checking the interaction of drug Ritalin and disease Hematologic toxicity for safety when used together.

Check result:

Ritalin <> Hematologic toxicity

Relevance: 23.07.2019 Reviewer: Shkutko P.M., M.D., in

When checking interaction based on authoritative sources Drugs.com, Rxlist.com, Webmd.com, Medscape.com there are contraindications or side effects that may cause harm or increase the negative effect from drug use in presence of concomitant diseases.

Consumer:

Hematologic toxicity, including thrombocytopenia, easy bruisability, epistaxis, leukopenia, anemia and eosinophilia, has been reported rarely during use of methylphenidate. However, a causal relationship has not been established. Therapy with methylphenidate (racemic) or dexmethylphenidate (the more pharmacologically active d-enantiomer) should be administered cautiously in patients with preexisting blood dyscrasias or bone marrow suppression. Periodic hematologic monitoring may be appropriate in all patients during prolonged therapy.

References:

"Product Information. Focalin (dexmethylphenidate)." Mikart Inc, Atlanta, GA.
"Product Information. Ritalin (methylphenidate)." Novartis Pharmaceuticals, East Hanover, NJ.

Ritalin

Generic Name: methylphenidate

Brand Name: Aptensio XR, Concerta, Cotempla XR-ODT, Metadate CD, Metadate ER, Methylin, QuilliChew ER, Quillivant XR, Ritalin, Adhansia XR, Jornay PM, Relexxii, Ritalin LA, Ritalin SR, Daytrana, Methylin ER

Synonyms: n.a.

What is Ritalin?